$NVGT Breaking News: Novagant Introduces GoldenCBD(TM) Edibles and Ingestable Products Line

DENVER, - (http://www.financialnewsmedia.com News Alert) - Novagant Corp. (OTC: NVGT) (Pinksheets: NVGT) is pleased to announce that in this month of July it will release its GoldenCBD(TM) oil that will be available in several forms, including capsules and liquids. It will be the answer for those Medical Cannabis Patients living outside Washington and Colorado.

Novagant\'s GoldenCBD(TM), along with its GLAVAPE(TM) product, is proud to be the finest, most consistent Cannabidiol (CBD)-rich hemp oil in the world. The Company combined the power of natural hemp with the gift from mother nature to scientifically formulated CBD-rich hemp oil.



GoldenCBD(TM) is 100% natural and derived from the federally-legal industrial hemp plant. The Company\'s unique hemp cultivars, combined with its proprietary technologies, produce the highest quality CBD-rich hemp oil in the world.



GoldenCBD\" is a mark of quality ensuring the highest quality as it is lab tested multiple times during the manufacturing process, from seed to shelf. The Company tests for CBD content, other cannabinoid content, yeast/mold/fungus, and bacteria like E. coli to ensure safety and quality.



The GoldenCBD(TM) is:



A natural organic (non-synthetic), safe, and legal product.



Non-psychoactive.



3%-20% CBD+ by volume.



Decarboxylated and filtered.



Made from Hemp Oil (Seed & Stalk).



Is from non-GMO industrial hemp grown without pesticides, herbicides, or chemical fertilizers.



Is stringently lab tested for quality.



Is independently certified.



\"GoldenCBD(TM) is an important food supplement that is in dire need for those living outside of Washington and Colorado.\" Said Michael Thornton, VP at Novagant.



Cannabidiol is looked to for its \"potential as a treatment for a wide range of conditions, including rheumatoid arthritis, diabetes, alcoholism, MS, chronic pain, schizophrenia, PTSD, antibiotic-resistant infections, epilepsy, and other neurological disorders.\" (http://www.projectcbd.org/about/introducing-cbd/)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.